Learn more about the latest in glaucoma news, treatments, research and innovations, from Cleveland Clinic’s Cole Eye Institute and industry experts.
We continue to see tremendous growth and opportunity for glaucoma care at Cleveland Clinic’s Cole Eye Institute. In response, we now have four full-time glaucoma specialists seeing patients at our locations throughout Northeast Ohio. In 2013 alone, 17,949 patients were seen across Cole Eye Institute for a primary diagnosis of glaucoma and 316 outpatient laser procedures for glaucoma were performed. (continued below)
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Traditional vs. Minimally Invasive Glaucoma
Conventional care is still the gold standard procedure
Edward Rockwood, MD, Cleveland Clinic Cole Eye Institute glaucoma surgeon
Case Study: Treating Primary Open-Angle Glaucoma
Handling complications after Ahmed tube placement
Stella Paparizos, MD, Cleveland Clinic glaucoma specialist
Challenges of Treating Childhood Glaucoma
Stakes are high; fast, effective action is essential
Elias Traboulsi, MD, Head of the Department of Pediatric Ophthalmology at Cleveland Clinic’s Cole Eye Institute
Case Studies: Cataract Surgery for Narrow-Angle Glaucoma
Faster, lower-risk procedure also can lower IOP
Jonathan Eisengart, MD, Cleveland Clinic Cole Eye Institute glaucoma specialist
(continued) To accommodate this patient volume, there have been expansions and renovations at our regional locations. For example, electronic medical records and images from our 12 Cirrus HD-OCT machines and 12 visual field machines are immediately available at any of our offices to allow easy coordination and continuance of care.
Cole Eye Institute remains a leader in providing high-quality surgical glaucoma care. Although trabeculectomies and tube shunts remain our most commonly performed procedures, we are offering newer procedures such as iStent®, canaloplasty and endoscopic cyclophotocoagulation, with iStent® implants increasing significantly in 2014.
One of our greatest strengths is our ability to put together multidisciplinary teams to provide the most effective care to our glaucoma patients with complex disease states, such as bleb-related endophthalmitis, steroid-induced glaucoma, glaucoma related to genetic syndromes and severe ocular surface disease. Just a few examples of our multidisciplinary surgical collaboration here at Cole Eye Institute include simultaneous tube implant and PPV (together with retina specialists), co-management of complex uveitic glaucoma (together with uvetis staff), simultaneous postoperative management of glaucoma and amblyopia (together with pediatric ophthalmology), and transscleral cyclophotocoagulation in preparation for a keratoprosthesis (together with cornea service).
We are proud of the success we have had, and plan to build on that success for years to come.